Joao Siffert, Chief Medical Officer Dr. Siffert joined Avera in May, 2005. Prior to joining Avera, he held positions of increasing responsibilities at Pfizer Inc. since 2002. Initially, he joined the medical affairs migraine group where he supported the US launch of Relpax (eletriptan). For the last two years at Pfizer, Dr. Siffert headed the worldwide medical team for Lyrica (pregabalin) and Neurontin (gabapentin) in the areas of epilepsy and pain. Dr. Siffert
Source: averapharm
Tags for Joao Siffert
See all Avera Pharmaceuticals Pharmaceuticals CMO CMO at Avera Pharmaceuticals Director at Pfizer Vice President, Chief Medical Officer Ceregene Avera Chief Medical Officer at Avera Pharmaceuticals Avera Pharmaceuticals, Inc. American Board of Neurology director of the Adult Neuro-Oncology Columbia University Business School Beth Israel Medical Center school of medicine
News about Joao Siffert
See allBe the first to add news to Joao Siffert
Websites about Joao Siffert
See allRelated People for Joao Siffert
See all| coworker | coworker | coworker | coworker | coworker | coworker |
Quotes for Joao Siffert
See allBe the first to add a quote to Joao Siffert
Directory
Home > Directory > Assistant Professor > California > Joao Siffert







